Search Results - "Khalid, Ahmed Bilal"

Immunotherapy in Lung Cancer: Current Landscape and Future Directions by Mamdani, Hirva, Matosevic, Sandro, Khalid, Ahmed Bilal, Durm, Gregory, Jalal, Shadia I

“…Over the past decade, lung cancer treatment has undergone a major paradigm shift. A greater understanding of lung cancer biology has led to the development of…”
Get full text

A phase II study evaluating safety and efficacy of niraparib in patients with previously treated homologous recombination defective metastatic esophageal/gastroesophageal junction/proximal gastric adenocarcinoma by Khalid, Ahmed Bilal, Fountzilas, Christos, Burney, Heather N., Mamdani, Hirva, Schneider, Bryan P., Fausel, Christopher, Perkins, Susan M., Jalal, Shadia

“…IntroductionEsophageal adenocarcinoma (EAC) remains a devastating disease and second line treatment options in the metastatic space are limited. Homologous…”
Get full text

Clinical outcomes and safety of immune checkpoint inhibitors in patients with solid tumors and paraneoplastic syndromes by Nassar, Amin H, El Zarif, Talal, Khalid, Ahmed Bilal, Rahme, Serena, Zhong, Caiwei, Kwak, Lucia, Salame, Marita, Farhat, Elias Bou, Freeman, Dory, El-Am, Edward, Ravishankar, Arjun, Ahmad, Bachar, Nana, Frank Aboubakar, Kaldas, David, Naqash, Abdul Rafeh, Sharon, Elad, LeBoeuf, Nicole R, Cortellini, Alessio, Malgeri, Andrea, Gupta, Shruti, Al-Hader, Ahmad, Sparks, Jeffrey A, Linnoila, Jenny, Hamnvik, Ole-Petter R, Mouhieddine, Tarek H, Marron, Thomas, Parikh, Kaushal, McKay, Rana R, Dilling, Thomas, Choueiri, Toni K, Adib, Elio, Najem, Elie, Kim, So Yeon, Sonpavde, Guru

“…BackgroundPatients with paraneoplastic syndromes (PNS) are excluded from clinical trials involving immune checkpoint inhibitors (ICIs) due to safety concerns…”
Get full text

448 Clinical outcomes and safety of immune checkpoint inhibitors (ICI) in patients with solid tumors and paraneoplastic syndromes (PNS) by Nassar, Amin, Zarif, Talal El, Khalid, Ahmed Bilal, Rahme, Serena J, Kwak, Lucia, Salame, Marita, Farhat, Elias Bou, Am, Edward El, Ravishankar, Arjun, Ahmad, Bachar, Nana, Frank Aboubakar, Kaldas, David, Naqash, Abdul Rafeh, Sharon, Elad, Leboeuf, Nicole R, Cortellini, Alessio, Malgeri, Andrea, Gupta, Shruti, Sparks, Jeffrey A, Linnoila, Jenny, Hamnvik, Ole-Petter R, Parikh, Kaushal, McKay, Rana, Dilling, Thomas, Choueiri, Toni K, Adib, Elio, Najem, Elie, Kim, So Yeon, Sonpavde, Guru P

“…BackgroundPatients with PNS are frequently excluded from clinical trials involving ICIs due to safety concerns. Herein, we study the safety and clinical…”
Get full text

Communication about cost of cancer care: Attitudes and practices of oncologists by Khalid, Ahmed Bilal, Urrutia, Samuel, Hanna, Nasser H.

“…e18826 Background: With the cost of cancer care rising, it is becoming ever so important for physicians to be mindful of financial toxicity to their patients…”
Get full text

Physician awareness of immune-related adverse events from checkpoint inhibitors by Khalid, Ahmed Bilal, Jalal, Shadia Ibrahim, Durm, Greg Andrew

“…6571 Background: Immune checkpoint inhibitors (ICIs) have been one of the most significant developments in Oncology over the last decade. Despite being very…”
Get full text

Clostridium difficile infection and immune mediated diarrhea and colitis in patients with cancer on immune checkpoint inhibitors by Khalid, Ahmed Bilal, Pham, Phillip, Maveddat, Ashley Varqa, Cunningham, Geneva Mari, Calderon, Gerardo, Hanna, Nasser H.

“…e14683 Background: Immune checkpoint inhibitors (ICIs) have altered the landscape of cancer treatment. ICIs are associated with immune mediated diarrhea and…”
Get full text

Multimodality, online oncology learning resources: Meeting residents where they are—A pilot to create a new oncology curriculum by King, Jennifer, Pham, Phillip, Khalid, Ahmed Bilal, Sabra, Mohamad, Schwartz, Jennifer E.

“…11035 Background: The Accreditation Council for Graduate Medical Education (ACGME) requires internal medicine residents to have access to different medical…”
Get full text

The impact of physician gender on patient satisfaction in an academic hematology/oncology practice by Turchi, Alaina Marie, Khalid, Ahmed Bilal, Nguyen, Chi Mai, Su, Jing, Ballinger, Tarah Jean, Jalal, Shadia Ibrahim

“…11022 Background: Gender disparities continue to remain under addressed in medicine. While prevalent in many forms, patient bias and perceptions toward their…”
Get full text

Impact of body mass index (BMI) on clinical and toxicity outcomes in patients with relapsed metastatic germ-cell tumor (GCT) undergoing high-dose chemotherapy (HDCT) with peripheral blood stem cell transplant (PBSCT) by Khalid, Ahmed Bilal, Pham, Phillip, Hassoun, Rebecca, Althouse, Sandra K., Abonour, Rafat, Abu Zaid, Mohammad Issam, Hanna, Nasser H., Adra, Nabil, Einhorn, Lawrence H., King, Jennifer

“…517 Background: ASCO guidelines recommend full weight-based dosing of cytotoxic chemotherapy for all pts regardless of BMI. The regimen for HDCT in relapsed…”
Get full text

Mustard Gel versus Chlorhexidine Gel as Root-Canal Medicament Against Enterococcus Faecalis: An in vitro Study by Zahra, Ambreen, Naz, Shazia, Mazhar, Mashal, Saeed, Fatima, Khalid, Bilal Ahmed, Hussain, Asdaq

“…To evaluate the efficacy of mustard gel versus chlorhexidine (CHX) gel in treating the most resistant Enterococcus faecalis (E. faecalis) bacteria as…”
Get full text

Physician Awareness of Immune-Related Adverse Events of Immune Checkpoint Inhibitors by Khalid, Ahmed Bilal, Calderon, Gerardo, Jalal, Shadia I, Durm, Greg A

“…Immune checkpoint inhibitors (ICIs) have been proven to be very effective in the treatment of multiple cancers. They have a unique side-effect profile distinct…”
Get more information

Knowledge, awareness, and practices of cervical cancer, its risk factors, screening, and prevention among women in Karachi, Pakistan by Hirani, Samina, Khan, Sarah, Akram, Sidra, Virji, Safna Naozer, Shaikh, Preet Ayoub, Naeem, Ehsun, Chaudhry, Rayaan Asad, Khalid, Ahmed Bilal, Khan, Jalal Ud Din, Qasim, Muhammad Suhaib, Jehan, Imtiaz

“…Cervical cancer has a high mortality rate worldwide; in Pakistan it kills more than 7000 women every year. Prevention is possible through vaccination against…”
Get full text